Experimental Hematology

Experimental Hematology: Journal for Hematology, Stem Cell Biology and Transplantation

Now available for android tablets and smartphones! It just got a whole lot easier to stay current with the latest research and science of hematology. The Experimental Hematology app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap.
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Journal Subscribers: Log in with the same username and password that grants you access to the full journal content on the Experimental Hematology website. These credentials will allow full access to all content on the app.

About Experimental Hematology: Journal for Hematology, Stem Cell Biology and Transplantation

Experimental Hematology publishes original research reports (regular and fast-track submissions), reviews, letters to the editor, and abstracts of the annual meeting of ISEH - International Society for Experimental Hematology. We welcome manuscripts describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis as well as non-malignant hematologic diseases. Submissions focused on non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems) with potential relevance to hematopoiesis are also welcome, as are studies involving experimental or early phase clinical cell transplantation. Studies employing genomic and systems biology approaches to the study of normal and malignant hematopoiesis are strongly encouraged, as are those employing model organisms.


Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps